Differential Regulation of Gene Expression by Protein Kinase C Isozymes as Determined by Genome-wide Expression Analysis*
暂无分享,去创建一个
M. Kazanietz | C. López-Haber | Cynthia Lopez-Haber | Marcelo G. Kazanietz | M. C. Caino | M. Cecilia Caino | Vivian A. von Burstin | Cynthia López-Haber | M. C. Caino
[1] C. Hauser,et al. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells. , 2003, The Biochemical journal.
[2] M. Ueffing,et al. Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts , 1995, The Journal of Biological Chemistry.
[3] A. Basu,et al. Protein kinase Cε makes the life and death decision , 2007 .
[4] F. Civoli,et al. ET-18-OCH3 Inhibits Nuclear Factor-κB Activation by 12-O-Tetradecanoylphorbol-13-acetate but not by Tumor Necrosis Factor-α or Interleukin 1α , 1995 .
[5] M. Kazanietz,et al. Bryostatin 1 Inhibits Phorbol Ester-Induced Apoptosis in Prostate Cancer Cells by Differentially Modulating Protein Kinase C (PKC) δ Translocation and Preventing PKCδ-Mediated Release of Tumor Necrosis Factor-α , 2010, Molecular Pharmacology.
[6] T. Kuroki,et al. Protein kinase Cδ amplifies ceramide formation via mitochondrial signaling in prostate cancer cells , 2002 .
[7] M. Kazanietz,et al. Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via Autocrine Activation of the Extrinsic Apoptotic Cascade , 2005, Journal of Biological Chemistry.
[8] D. Terrian,et al. Protein kinase Cɛ interacts with Bax and promotes survival of human prostate cancer cells , 2003, Oncogene.
[9] M. Kazanietz,et al. Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. , 2001, Current pharmaceutical design.
[10] M. Kazanietz,et al. Regulation of Prostate Cancer Cell Survival by Protein Kinase Cϵ Involves Bad Phosphorylation and Modulation of the TNFα/JNK Pathway* , 2010, The Journal of Biological Chemistry.
[11] D. Terrian,et al. Protein Kinase Cε Has the Potential to Advance the Recurrence of Human Prostate Cancer , 2002 .
[12] J. Falkenburg,et al. Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia. , 2005, Blood.
[13] S. Gringhuis,et al. Convergent Actions of IκB Kinase β and Protein Kinase Cδ Modulate mRNA Stability through Phosphorylation of 14-3-3β Complexed with Tristetraprolin , 2005, Molecular and Cellular Biology.
[14] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] N. Suttorp,et al. PKCα and PKCϵ differentially regulate Legionella pneumophila-induced GM-CSF , 2009, European Respiratory Journal.
[16] Yoav Benjamini,et al. Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..
[17] P. Verde,et al. Fra‐1 promotes growth and survival in RAS‐transformed thyroid cells by controlling cyclin A transcription , 2007, The EMBO journal.
[18] S. Salzberg,et al. JAK-STAT signaling involved in phorbol 12-myristate 13-acetate- and dimethyl sulfoxide-induced 2'-5' oligoadenylate synthetase expression in human HL-60 leukemia cells. , 2005, Leukemia research.
[19] C. Gélinas,et al. Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor , 2005, Cell Death and Differentiation.
[20] U. Förstermann,et al. Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells. , 2008, Free radical biology & medicine.
[21] A. Basu,et al. Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C. , 2002, International journal of molecular medicine.
[22] C. Crosio,et al. Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis , 2006, Cell Death and Differentiation.
[23] I. Verma,et al. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements. , 1990, Oncogene.
[24] A. Gutierrez-Hartmann,et al. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells. , 2002, Molecular endocrinology.
[25] C. Marshall,et al. Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes , 1998, Molecular and Cellular Biology.
[26] R. Tjian,et al. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.
[27] A. Sytkowski,et al. Protein kinase C-epsilon is necessary for erythropoietin's up-regulation of c-myc and for factor-dependent DNA synthesis. Evidence for discrete signals for growth and differentiation. , 1996, The Journal of biological chemistry.
[28] M. O’Reilly,et al. Tumor Necrosis Factor- α –Induced Lung Cell Expression of Antiapoptotic Genes TRAF1 and cIAP2 , 2000 .
[29] N. Suttorp,et al. Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms , 2008, European Respiratory Journal.
[30] P. Majumder,et al. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators , 2006, Oncogene.
[31] W. Kolch,et al. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. , 1993, The Journal of biological chemistry.
[32] A. Suhrbier,et al. SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. , 2008, Cancer research.
[33] S. Reddy,et al. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. , 2007, Cancer research.
[34] K. Belguise,et al. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells , 2005, Oncogene.
[35] M. Kazanietz,et al. Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.
[36] F. Feuerhake,et al. Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation. , 2009, Journal of neurosurgery.
[37] Peter J Parker,et al. PKC at a glance , 2004, Journal of Cell Science.
[38] John Calvin Reed,et al. TRAF1 Is a Substrate of Caspases Activated during Tumor Necrosis Factor Receptor-α-induced Apoptosis* , 2001, The Journal of Biological Chemistry.
[39] P A Insel,et al. Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[40] P. Blumberg,et al. Tyrosine Phosphorylation of Protein Kinase Cδ Is Essential for Its Apoptotic Effect in Response to Etoposide , 2002, Molecular and Cellular Biology.
[41] K. Nakayama,et al. Suppression of Apoptosis in the Protein Kinase Cδ Null Mouse in Vivo* , 2006, Journal of Biological Chemistry.
[42] S. Anderson,et al. Protein Kinase C δ Is Essential for Etoposide-induced Apoptosis in Salivary Gland Acinar Cells* , 1999, The Journal of Biological Chemistry.
[43] M. Karin,et al. Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters , 1987, Nature.
[44] R. Craig,et al. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C , 1998, Oncogene.
[45] S. Reddy,et al. A JNK-Independent Signaling Pathway Regulates TNFα-Stimulated, c-Jun-Driven FRA-1 Protooncogene Transcription in Pulmonary Epithelial Cells1 , 2006, The Journal of Immunology.
[46] T. Kuroki,et al. Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. , 2000, The Journal of biological chemistry.
[47] R. Medcalf,et al. Plasminogen Activator Inhibitor Type 2 Gene Induction by Tumor Necrosis Factor and Phorbol Ester Involves Transcriptional and Post-transcriptional Events , 1996, The Journal of Biological Chemistry.
[48] L. Yin,et al. Overexpression of PKCε sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1 , 2006 .
[49] J. Neoptolemos,et al. Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. , 1999, The American journal of pathology.